Table 3.

Clinical outcomes of the patients

	FVP group (n = 32)	LPV/RTV group (n = 31)	p
Primary outcomes (day 7)
SARS‐CoV‐2 clearance	10 (31.3)	5 (16.1)	0.237
SpO2	93.0 (88.5–96.0)	93.0 (88.2–94.0)	0.628
Temperature	36.7 (36.6–37.1)	37.0 (36.8–37.0)	0.066
Respiratory rate	20.0 (18.0–28.5)	22.5 (20.0–27.5)	0.108
Secondary outcomes
LOS in hospital, days	6.0 (5.0–11.0)	8.0 (5.5–12.5)	0.140
Admission in ICU	4 (12.5)	6 (19.4)	0.509
In‐hospital mortality
By Day 14	2 (6.3)	6 (19.4)	0.148
By Day 7	1 (3.1)	1 (3.2)	0.999

Note: Values were expressed as median (IQR) or n (%).

Comparison between groups was performed using the Mann–Whitney U‐test or the Fisher's exact test.

Data were collected after 7 or 14 days of randomization.

Abbreviations: FVP, favipiravir; LOS, length of stay; LPV/RTV, lopinavir/ritonavir, SpO2, peripheral capillary oxygen saturation.